Effect of Dexmedetomidine on Pacemaker Function Following Cardiac Surgery



Status:Withdrawn
Conditions:Peripheral Vascular Disease, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:Any
Updated:3/30/2019
Start Date:February 2016
End Date:March 11, 2019

Use our guide to learn which trials are right for you!

This is a prospective study looking at the effects of dexmedetomidine on pacemaker function
in patients who have surgery for congenital heart disease utilizing cardiopulmonary bypass
(CBP). For the purpose of the study, no change in intraoperative care will be dictated. The
use of dexmedetomidine will be left up to the discretion of the treating physicians. The
study will involve only the collection of data regarding the amplitude required to capture
and specific demographics and intraoperative features including cross clamp time, time on
CPB, and vasoactive agents that were and are being administered. In addition to these data,
it will be noted whether dexmedetomdine was used or not and whether it is being administered
on arrival to the CTICU.


Inclusion Criteria:

- Patients with temporary surface pacemaker leads following surgery for congenital heart
disease.

Exclusion Criteria:

- Patients with single ventricle anatomy

- Patients receiving epinephrine

- Infants less than 6 months of age
We found this trial at
1
site
700 Childrens Drive
Columbus, Ohio 43205
(616) 722-2000
Nationwide Children's Hospital At Nationwide Children’s, we are creating the future of pediatric health care....
?
mi
from
Columbus, OH
Click here to add this to my saved trials